i{0_'^8spNd8$qb"@HBk&%ϛ kuuuUu-}OF?Ǎq`9M*3y C7iT7䥚,g[Og /N8&M0ys} 8ìN8vX룛T O ]{&QBj[P`?} S.?Ϥp%g>޻2[~OnOܴie켩v?!-> =t7~8R|5Ώ@3Yq*MvH3+f >ZIbms7mՓÕߣ=tع/Hw>|ycvm7OwƳ3UW( F+}2 Rׇc{_JΗpA+%k~v/*{k g>x`| tAK v 39X{e](-_.0VGa9l ޗޱ//_> ˆ&s55I1sZv՗//>f_| C0&J/)VPA?K}#G_f=Cuf][xJC`ޝZ|p)-^gΙ6Q@ 1fݣ//卺v8|0??f "eX&m)>T@Hׇ;T]GxH&4C3);:> I38{ۖ潳 }49,l_%y37wH=?|925,yܫ_nË!F#< Ҿl~z1i`݋ǒ{2R)ҹ|\ܙq`n^#LR 7{^^EsY::>]^||qغZ\noP7~5ͷ " ŋϷoax8ZF-̽ݘOV zr]04Αx@7-/rx=]xf矃ϳK&|ESV>$pW׻v0쐛䡽` m0P0Fv29||~ !X5 :#PR8'o!8ì 7]8˸%ŀ\!4XeP-b#C}׽xkZ  "M=FwTp s%ÁGRx.2B*80C<9 Q]Gz}d7)Q]DQfyhޫb%ќ=ab$1?^ߟp򳯊_dVn.%ѻ櫭#QϼĎ> f,Zɭ)fNkHĮl` <:}z870-UBΉWߝL |k6>^;˻ \0e]`*%Ik`&>\ۭXB'BgK]JgOhsmf\\wQ!txu! ZKG<[ӂp:7a<ݯ_&Ν~Jp|mKn]KXA;wtt}q{x:f$J`02J4̃g5\vl;:FmWH5|wa9r҆KI z^XԟlupGҡ z6vί_܊Rq˹| T8:H.K` y_:Y GghߝGnk0#a>8M; 4w~{м@u|O>qm3qؗ7_wz^F~M~8[%}xQ=`$0`!%R/:Y^^8bQ]P3$ѻK `~C:& NjZ6Lݽp>V@u&`&kli{;\ǢNRPK}[)a)vl| .6zF >3 ?*^v>Xb\o_^|g^:ӮqO3~zcꅾ{{_fxS|xڻJփ /̻/ēlPʏj?{$@>,~b|::8ٞHu=3x y{3%x=9۞@')]ƀM7k-;e{p`|4#xɏki|-@K!KT{55$r3PAn@)yx Vg]0qi8y 06`w+CS=(.v^Fvf5+Ѭ lɻȸ@y/ =@.|Dv Avέ{=C_RƩ1(<;bȂ{DNIY| %gyB 3R ,`l0:VZ^XLwz-zb0R=3(vJ_ }@ @\(@A~䕤Ɨ9^ Hvr6fC?qfKwc+ Qp\"ЃszLN3,*ޱkA9mzjh':g~y>sֈj剞G+kQ?q.rV.tyW 3rbQ%s9D]!eO}i-Emdzޫ:z] a2Ai=f/r>"[@I]ƿj cC]V~Gpx8n\ASAO_vy ÁsW9wlpS=cR(NWFXC4%V%e)}fƁ?x{;p5zX@.Ex6=1B.:[ropz|(m*< KK5={ YqTG;_8В QTH8lKRS>E#/b̉K T&/ޑyerʫp9jt?J 'BpW/b2A@*pBJ#[A8Q&^vw8xBţ/gA >+=sFn0VYOzc "2DZ;)nI%~93 <٫A Y|%[-\0 CFu,,rwbn_0#m:FkẄk+N~n҇(kDr5#ǷX G3F{ Qb(1H,`c0`5k{&ΉtOe"*Ye215Dcm@.?_N7;yU:9R *Rt䃾 ^300rQa&`0,A5 ?{$S|"p1 EdY3Н 1 UAy*Y Jy P`1j"uw+!C\ZLlv߶5*<ߊhZpۦY{7NؽEoQcgp)L?{w s ^/=c0QR rKd5md;6,_\"9 Htfܛ]џΎ_xB+ˋ?zf4(/3\b ~N*=/ȳE.NAAy KiET54<5Z[sړ0߶1A nbD҃=qiPi!n=D7r@x;# $9/W {$4מ QY]qD1ju}s ӧd},@ E3 @&}gLTb}uzIk,F1Fpr)AD(0WXNs ~<<(GWqQy  UeB#h*VQ[1`4`Kf ݣOj8Mv&NU3n  e[ŶS]iQqQ%W7Z6/ 5u1?P++k`_v M 7#܀I/ʧĺeѧˀTxPFTcV;&/\\[F*sf}-IHW:aAK@oy'~OC>?;h3XKZ2}:H6Ca Ahv6 b@):ֱڸay N{q `"bJŗ/O_sPj@`1Qㆀx_&G2>~8?C2o~9'/&τӋzD'ç77'Wz7ٻǯ$ZODՅI::69m E&|Y /ŕ=Ї^=d쎲:~&|ޚ?sb=oŇb{r^7?9}l`|j|{/gO]<8|KߞE>X sեvw{^};oiDe^,u֩&wEq7>M޻/'/&Ԯ_<{:=[Bfx(~DvfDW;z|t~z&qť}~3/}̋yt#8G]7ﭛy07z4>;zn1s1|/~=q}tKrׯ:z毓oxvk0P/y7һwS/ׯׯO'7ˏo?~ U{tyI|twd6%}%V&]o/.<~~[^>_?WO>8> I|W]ᓏO|c$vnl g'???}2Q돁/wo[hY~yx}ï_m`q}z"77 tFz;>K*z#}x}}vGhs꽘?7o!w`XQ?Oo,G]r{yx{bpp=o7Om݋lB|oPKÛ$<8>|oOoù79ZK8R_5 ûm0>~s)\?W?< .5|"ztq/=W/_.ԢɳۧWoD_W7⛁x}>/s;2'߾|돋7gwgoޓTϼq&L|zً}O7G“<|s;Ҟ/o:Zx1"k`}8:־Gǯ~zg›Ϯ߮_]~l,_>;g/g[/>;nDoJ.vgϺfKW.G-wٲt;;s{}|{tg)9w>\LJ7dw}hu>Ҏ޴+K#I;Q.RޛwI< >x٭mp+~t;.{qo_0/n4M{ w`.|pWه:uo~|:򟉟4}o7B ۦy?b`?߉ 'tQw_ykb'ϟ\DOnOCF}z}p'/'p9O[>t`վ~s%Qܺ}^}x{>7͛(.gӝzʶ_^~;Oo*r}l}?|~]7on{|c 8~se/E)Y{'ǫςf~HD}d7~[r=xzÛ'm@W/N}V_]~6rc]/zqzx|OP8Gd8_=? zP]<-P'/|xq5P[n'A?՟ݾ5_y<~7ol)p?\Ow?.'#b}g/콼x'M>k >b{oޮ 9]7Ov>%]|YO,7Cp"xͳ'Gtk;8[/?:/Ż@/=~j=djNk[O?DnfO>G(j;@_}zOW/uP/ W^rw\q<Ӌ ?ϵ.:7it!,~U.ޱ77޿\'N>/&&WOB{s&惓ݼm]\z^{{e?/BN77 ~/[c=ym/j}:OW. fpzus}F_y/Gwqt~|w_}~{w}T|/uw㷷իW7Ӄ'/OǡͯvOjeQOګҩ} '@H}em<Zz<><uP=Gx}0>^7ۏn(xPTP'{_>\O%9$]1;bA9+R |(v_*cFroj]l_X>qUa;.h@)q_"9xr8ehi0O^ЧςoG/N*֧'R&.jcC|$g]Mm 6 _Π?lInn9#㱖OFrM jԭ”Axu #} fȧTci5&" ڨDr@We޸ZU*flP!;~(RNzhvNA:ǃr|Ѭ.kF<д]z+p `[mQ~{(GzүPIy֔I I78OPAeGv>ALKݑ񡛲la0oǃL)زi8%4yv] %\ޥXϢ suse:iGCDT0D_ N,QX߾ PY(?J [2Q^(L|_+oOrMWAE Tsf͠B%:1זFYn~ z ?@szD!CqB+cϮMDN`G5{{k/ߨB᪔cŨ]6QWl-:[TK\a>_2|_6_O4 bRPa*pY0Fnώpr{=oxrgY#\H fn:-ne;TXIUK>)Ȑ!G!N.-ZzKakC6]M2}UǗ|%^iۓ=h 7aGsyv})G4ݭo5!A;#|F?Jr >o9Qc1DbOmrNՄtxDE~g#Jl/[@xHQWpĵxBjT&+ȤLj+(RW"[44>Quta-!!? uKLe" sA}FılnmF̨f~TQ|1졎C-Wz`b %J?¶m6ec@Y M.Թ`]u"a~ }ߞsDž/ lA@g*g0/Kyn V FtvK.lq2}TS,`ot+e8s[Ås~y)v]\.ү_ez\`/r}}7{~?-Lkq.E7e? ²NOwT㱱!W pi[i| u@cR`]:ۣ{!pZ8a azr׺F8:ӯ_]4@we#Gj—hփ?LRlwe_x-ǃS^ +=C~XQq@w^ |O:*\]@AFyNٷN83$>6N!qe6[m{(´[Q֖CZ^g+?}?_ ^/g4q-'3_W/o利k|i L7&UI m_>=z?o/ l|B#.X%XG|tqڃ#J_sO9ޭpׯ-L 'U2x t 8| $~yQnMB5o%[.X"@},Rf-5^%~=+HSݶo%j$Zؒ3 X-FiHQi6N?UZ͆TqO}|dFLz|Q!7x\CG4tIik[]k@g֧ JPΧQ:&AOEGY"c'4b%ۭ rB}jk|9&@"0;燮.'.t:(i?RmW6lj;iʪvjZ %c5)k y5p0eW8 =sBu*u|hC=[f.P5 [TGse<ʆV1&ΡZD@m>C> ë?×48v/Ǐ.`pOtNQig;5QG:9 d1kՃil7l']vM5Zp]6 ^{Mk>G.[ Apm7mRX%KZn|{<إ#=7ÏW7{kCmc3;s^u :/awF.܏F妚o\mtҵgF3# P'}=326WQf.|MMv%Wt1ĘMk@ 8[+*Q6 (/h,|p(ڙ)\u}SM6n5* ,Ftە&w?.ݶۆ Js䚨gr s]k}^CӮom4 wCwd0#Sĝm5MYPTp}5}#0F$8犱"  1Ը9fdgR_Dڮ?hE;Ӈhbka:.kJƶr'{>ue4NVc+jCk XJ˶Yb JB\XgPT]Uiih N6 pDy΀0:Aǵ )ouR+SLSB +;/[@Т[ԇk&"8y?аSv–)8VV^yp''8Rԉ-4F(+2LOG.tJ"C0܍n6YMm GDW\]I1ܱxw`c YΨjN\{Ӆe5E+HaBbHyqJ1]"2v+~Ƃ7x.Q峋 WV"$u @VKU%fʍ.)d10CwuQnڶ͏)rhvhD` guFPY0%"`9yXtbέ`_,d[6)iz`#,vG@Oe*h, %q’oyǻgXh6FWpT~47n\vK7)1%Sɏ^e~l r`n5Ohm(l:O&F˭׬3dhFe3Erm 1xn̴=;[pEb2N^fR] LrP۸֕[M[3C2&b50f472ؘh?MݬzϟxW|CCdK'Dj(ubXs_z-n,IJIxm. 5( +{dO7O"t@e9&B5a^et\;llÝ;̅>dVzfVݹM|dQv%kRm_ml7;"><o(imhхM,!u2=M- ]Ki۸M6"{tC@n3JTQ95 EDisn9qIU"\z+Uv;urE:E㌚ D< ^dyDEL.QPu(?gp>4Z/P4wjAւ('%_顤V" ԴHN<ȈNòۖ8np+f'Zji"5e܊֧C LDfr(*wn$㖏+ÌT{ 1OU]yrV(YfIϏ CexMY=6/L\[bK0D;h1T$ܢ9tOR詁6i?+ u=MG_XZ#N;mT%xb c UQp׫#U=<(UA:`Y)!.n2,tЄʪ0U䁦edl60֏F)qU!Pxʝ=.oːLѴZ2uB%Cxm4Sfk l$WJH~L= LC!^2k^G>@?rWӇr7P;ag۹L1nttˀ|&l@ 5R Mo<t)Y| *e#4uzM}"K KgbBr v Pa[(!ڰٲWWBJ&,):'2@g;"q7iSw:Ċzfk4+ Cei,ڠޢVa6Y3(6ÀFQ/-[\ A or >D@jWm`#ϙ&S}m`b@E&j&ZM󅪟+*~}6nh`+6 xs<[ɑ<mS^| V=rzwKoNLSfZ+{'Ŧo.Sv RPkX8sP\=2kfĂl-ìbemM&:X}帹ͅYs%3»r;Va+w#`N#|dF?yk\/7w~6fu=RI! Dh#^ xٷ2mN@7[+iYk:4Y[ *ZՀ:_hHДQKK-)U_W\eG }r ab5Sس Z2ӱ: ܨ\k, Y"f[1MMkj;$(uw9ᡫ`z)!0bRR+h&6աb))ʯvId8Y*7l=(d.DjX]6 cI!WfY]IfzOY!sSknŻq6s6BTNԫŸq x~@7$3ώX)HDmI<dfOa ! fyoН i#qm8]sT#ԺCFs+tC:  +˘ue9oSI1 ֙Oa%SO\n쥦\&ME̠>4k=5҉88U`ٙXsQ"^G ~YzOܑ@fNP7J7MZWj[BoR `WAqSK *&Sih600]PUO-z(|*Md ok3PXIv2E̩0f b,e\3nG[Su+.w o1p-ʫO oV#0~/*FDQ)kb VIȎ"m!FmH5'k" yv2ޤjçkLwH#gC}VQ#٘T:A Ii향Kcyl$Kqu?ZfŁ2y?2ٖBHH zڧ j=pG0&1*O~3ru}7ץ&qtl/jC22r#ifJuv'?\~4Z=CjcMl˟lgOd*m&1ʭ0U,k䨗mfyPemd#-բ7t'Bkorᛖvu$JH.@+Kt=ܴtw -b967 lo o)+֊*a!0.9o^dɷbK@ SD(Ym #i,^btR~((KoB[ZC\ 7hAk^lРf\t>/%O#ay~n˲r"1uD ¿uXsfaj2<˜+b`Cu-+`WA^ZZ5kuVLym7E'R#Iw3Z8RFC9 34wqވsYO"^̵mLfZs[M3[Ü玩6DS S{w/W;Ay M|1*!;u|6xnA 7 RA!@57I`D8nNɝ>0镒?Yef77 -qB|v$_8 σ9Id=]l{~Դ4m]QqpWĵ7Ik#opfb9Yأ"eD-BNt1;I#hĊp:aI f9u71 O sC{ϰد.Vb x`{cxY]9ZZvY«+T\IB,y`j"t"HXݳ[_vGhzh\Y_m+D$ 9frWw*ŀ;fQH2rvsZW5˘ 8@H9&E d. Ƣ] ʔ8Rn(V"Ry%a-Q`3Ɍ'A6FNIuA7e&urQ$\DAZIAlGs%cձI)tU?0ijN%,Ej@ &TxUZc7lMO0'K}5C5U+EOd &!v0fQo3&wh+=YUN$^3(uC{ARXb$W5kD;3Iۣ$JB?PQ~pʬ)o5qMc. An %8!!KKWt~nV/~ٞC(7![E,EZ/Mz]I;Z׉ .|5u퉀 EK|$ !Fj #Խ57|K׉h3Iisfs|ךyYM;I:2oCc[$ީ~:'x[@3}[MNYV;V/*r~mhOHͅ26 iaNn&0ëDLx 0ܰ5,<P s8Ic>M+[`g$>WlhmWFV%m&CTB!Fـ5>e^Ir? Jp[n?+;AE ԰CŏҰJXߎX:B( Yyl9gЃ$-@o6\%Y.)81 :%@Rӄae|ldu䜄҆\O  OdڲBy/g,/+$Udzi28j7]Fb:5QQi"ѽ -4%Ք!hmDB|NŪJ,GqLoobĥQ@Kh;.tI^l?l'x5"2 ٜO[;4FfHo*0T=NNujC#&1AnZvh:Mg!3?lA!7zπ/4< 7nR+\K柭qf׆aI$5$n讛 g\Zv.^Q/*SC$xLB__fӨ[}誧$$̄fR]! Zir,j;EԆӕtZ*U|ijKWYV8OlS2b 5^Ã8#?I]斀:rIQ=H(=&>DDz+[8cM)L^y7j;0TWRfǭ8NK#v,#&ď xuV&Ji H#L݁:ْDTs,VZ뱥NN(7.CP-( v` ! ZkЋ]7$Jtj2•sQ&uޚZ WSZ0qloB|ez`fb;ˤ~+ϸ^J2qf~BX: MvDhJ*[E'Gb ]ӣEexε T*%?<]"!c̆7FYl\f5FQdl _9NsGr %(nxw=+2J4zn`J ӘT9UuB[2^\7+B$,u)Աs1=1C2/v͇nͤ(Q̵TI 3˙XR $yRW@d&w_yC„wPĎ?|4 3vH#QIc.dlxk7pR 7gL Ǖȍ/HmFVZpn}U?QqXzScgLgySjk+'Iܴ8RBa_z=yD#I|'.վ\)`KKŦѲNek[3wlr@dKP0be"rphbevۊݐXQ|P`8a( +`bX6yZy/xqj5d.X cXI"I]=+-*`zt! o$%0q>t+3,LX!$T[Hm87a"_YD`8<^fh "?ekijAfKsry#y㤪  L7Ϡ6MQ}>$$Y8Ե$C%%f"CዛPa=eʀp&zO;"CTCJ2!:T64ԕ`TPl vp{a`nQ)*CGm8,^u-^C%2 h*%@/L,P3)yiPskIP^hm,(S[~vBEMDך)l-tY.s'$@<4diM^6z-'NvjF{ӧI:j9~s~qߋiNĊé~4r(5IU4!%XH@*}ټ iJ ,_ibebA&TvDC>(V%C+g<2" pI7 mwȐv1 åٚeOCw'IVmv.f(7ǒ5"CSL7`yh$ЪӐ%Q̕B 919[鑘{LvObJ1by\PԺ_@SmoAg&:hV0.7`L]?=:.RD~ԷqE:L'SqUn D Uƛd] T) Y*ÏL!A|*65&d-f6yNasOW+q*S"NFL3\3(G"AJhQ80)R-+ -'զP5Pj-w҉؝-$ JzC!'ɊF0HI4AISd 噿\8KW(BgC(#?fgl-CCfDhW-3]ło#V\SekR4kYtFn[8 qw Z2[X[YsN ٬3θ-mJAEZauly{5e9|%1DqT7Ue'J(/Ly9`$H%=* I08rC/)1%?*RcdB&~:I4wxvkx2r q:q<[(=gNw+wK-6a<{Cځ;n01$cik܋eEr swGTB7r\TiGEѵNyj9~FVmxWzQR#c!,"nu`fv1%m\?rj,\T#2sP|W4c r)qIxu j2U?reUȏB"FCa3ހ*^k5cMXEAS)Tpp&ܠ9PsM/_^aţ_N|/-]1),ҹsuSAC9,cYK eLQz{~> duT77pKugt: uǙӂŲ,5xU r2HhL& a2ԺXjºLE%)F$k.Bi92\{9&6=ldkV\U.5gM߆>qg%KH[3M&ebfF4s( !VkRf@Qg 68yUʨf!gj-OQ2nV-g)nD6H$ \z*awޥ𩤴&a٠bu7#u 3 T$A4)PfmE'p5Ԝ:y,1Hv6@<Cǎ܇%e_AdܩZʴ]YiaU}n1 m5XQaCqx:GBc4ⲘQP_rNFvm'} pL˦9 n6iޖ~ 1ݨb3jJrB-0j'|7m$vqZxdzg?&Rvv||@$Ga=}l p4+AlWDf8EbQ"uՆ,݌J=j s[hMVȟbj'Ӻ,6$فCNplgK ]P$.M]"DLcL_'RSސ {G ! Jot\E(&^a3M(`تAuv܈fiqz+bl> # Y1/w6cL|`="J>F^Q\"ʅxSkqW,~BQaV"KOjR)1{Y*\Kwt5nY Ll Xs@LޠuHd$SyW&"z\3ߍTM߯ppD+Jͦƈ U#ɵJܝ=%yϢ-RP6+5jHO*8_sr ɏ6Jb\>0 rAʹM MVQPEץl8Y=qni4Fnhtɞ.%g̈́T"bvhm0PĆFAt9 DŚS EFˊ&C0Ngx(5 Ub#WGflYέ-kӟr!q>&ʵQGhDgKQ5BY wt,vRRboi0 Ul<]~E&k6J65CEoM$j}{\!Y,~V72,+kT [(={;X&Sb8틚r/ J$pLf(pg%ϯQ⛖3_A8:ȓr쇈. a(T@jbs:[.O3VM.FVܥRǨeqt;3le$B4 M. t`[fJ7`ov)v  kDJLFu !Nq3[$+.ڭ`Vi`67"tcb/~&ց`Hn=sucn8|>֙":d4Flo$ H=*<, CaMAR٭u@芔#p ٣b5۔+Uŋ! 1 zp_#*23.)CуӄڱWKe.EgZ2^ļk%gҫKDvzDiB[N]cL12KHlV槞$0JVpCc5H_ಬh0hTOm]0丨e£5N 0 C}NywIF-SrEJ;M 1 1]jZ>l򊝒ۃ_·?^RMvm\ɫ~s5)"PdhB}QNÜkk*z㡛$QҦQ.k.x%bl d?^Pe;h`>j01 ٤ tH >NWkL-O\U=E478,\:F߅R}%3[m%^S FRNw X@h %䚗ExZqi[ 3aq&>Wpa9G*)d~[͝ޮ*^aKEZ xNEՋ|3:Dlh&L&r![_:^EkZHzdMc,ϛc%h!*}҉1,Zz;_[ز$K5jcZ5rbڡ|Ćִ1'7|2lZ6n3rqfg;:I,&<̡8Z}S'6UX phzBQM^FѨ,*7FGtB}4p&ޔ R|hR t[\Q774ٖDCs7+0!z7(e͡rM(\+ 9' )l(\CGFC@PȮH)x71T6g{}M̫BFf?囖v l?X(JcS{`ё=+WMJ\ȣs:X˛z/+s:Ljb7W,HBҶ6m} Hv9P.?Jz mRk8cKǮ=&cq'^*lsW5Y8$n T֙.s5.&M-5Cؗ~ꨂV8ҪGȝ#9Z (|nNspg\ɍgNAk"tw4sT5Q@u6@~G"1-vr+{Yj!@s1l,]qFZD숇_eDƌ]*UHs7h;qRת0Ka30-K,tl Xy*L-KHTH2QH2V KJ F[w 00Y 6B^Yk/۾"KjN6&՝hhpsEfW 8;pCt7_bQޢ"#}l!4|iNj`Rٞ^<.ִN]̵6Xc Ys+qu-$QklR^,W:'/+`ENCϼ=TcFEv!Qag,UcR.4_h*KTzHP=>H>ZiZTDl:%z$PzSEw-47\E-C0ѨFFRHYFۏCKE@K9]w|oBm sd(Yh*T /=\.9 r㕴]$H,<2j(m׭<#ق=nmײnSEU"}P׳t$XJ {hY#$p345}Agx2lC I5UR2ebBW)dLĩ˹M5[TOEthlkx[5 l~EnTp3-CԩmFd915tT:saMՃ12+15 '}9wԡnmxRkAZ?Z-{dxIRiHQ+`*ei: $~[4bm!鴃ߨe:؍ڥbàC5^Xp㫊|&Je@NgQ#v޺jN^2c]VDK\h͔n%'+꓏ E\]P0SJp# Tdȣ I<=&X? ȵy0e*΁>K"&ɢ,htT4Rcu]/RDCR6L:TKT3'G7=( b13v=QQ 1KTԸRPӣUU!`>䥫3IWQQ/KLmdƀUyKQ'$.$jeWJy>1#)N_HZ{ԩI$e>??J46nMdaNى2fIBgأq##1*껍䖒[Do0yFAcCIrOF2 mz*LNqA`sNj+t=kɬ/$}`PӖ ,֝v7AikbA?"3v!Ҏ$\P"(̷Nҳ5(Q2:Ts;6z{6Ly\Ͳ ;XY x6Kn\4yw0`I;H(uV_gFK:wnˉl~$pp4ZsFhbDZ `2ʙ#p3(;ڂWT^.[Y^}vY5&FʌMK[&q1d~ǁU;rmfQ "+k[5 {fB`nܵNyP(M*[l^uH4YL=eI$=7iJfRdg0SW5 2Աf3$3 {52Di7]x Miڊ|TVKbR%B-hUub7qK<)̸1ӯ*9Ɠ5 5-daޤ.sa*vePt7w%  r{Nj }!3@6f, Oa(^D {.(%? mȊ36V̄qg4{=j(1GnVWt_I@rXBZVnleGlL̇#T5 ]J)|PJYXiax2Cfo eoڏ\*,h\*[9STV @t-YIhl9ҮqqUNo!ܯj8{M\IS )2sD&;B$Q?th/'ͪvXeePR2$/V ΋֫Nzv'-{XlL [=,'|ʸ!7Fɡyv+ۭʴLւ7D%dBە.sEyܐ0(ձu 9kôT碼5-UEfMIڲlIhLrY?SbUHBr{BɜEYnvc}3lq(.Tz WbtTȝuZ? ԧ43dGa_$Vi$-T M]ܯ2X+Z_sI08hTH+THbErK sɷQN hu~)gI˗gQXh HcGEJT>jjIl5EzMR7jsZz&ר+]dX "g h&UQ]v1:9꿇]Zu{ Y0Y8䵾D)8ES$rMeLSl,Z1e!QeX@q7GE5Qޟ!wi7m7XUG } ]F!N+]4^PX'~5=ԗS jPqDbC˘v>GDZo[k#q6}F(1V~Q4DׇkNpjL;sel1QXY4JnjF3k~8, sjBİt9m W7kS"t]E6p>4R 뇇Cfq[<.ZQ.Z/\]I1ܱxxńjK2!EY%BqVT(ֵIMj1.c[trF(4i#ùԱ^:1xW`_0VɈOcGz0`@Z@Cn^j\$'eA'HsIATi l+zeL|Y`9j'6H+ʍOnMR -=4ZZ*iԬ֠c#wjmd~4++Dt[k֛> h*FJQj|\!Ţ$ˍ75]"8G@FP2\s5š7((E3o Y7ە,r!d:[&㧉%vE"f1es5t,PdDX(VTdLrgDd&&Kk`%D]ODCîH @WS \w ?\uj^heڃ{dK}4zf+kJOT]%ZĠ ]s=Le?#xLj L$$DhOܡ0 {rI:K! }%ݫ Se:=1gSQQRX_T9>!| @䕪ơ KM\{\ }xzqE|x ]SS91;Q-KQ%gB6߯^]1;kpCv1>:J kؗl1]aTldQJl￞1`LH>cxvkx2r q:q<RĞ/RLL0ТzpW$)7\e>ځ#.sAMK_䇤s4 eEVĞY`ȑ)54S{^e(4-Nƞv̿}ӼS9"&ǚҕ񤢸 Ne5(Y-$ǿ sKDc?"# |Qd!NЮkVbO'BcO3,stLT,$ RO /t}S6홒Z,V̯f&=,NMBe0.SbuJ573DZ>D,Nʄn*Ka]KG4r,$fpڨ=01Fд X8/s f1L)cA!> OI̜V$rم p NfНdMso꺦xB6eJ1Y=hbi+ҭ=HdrvɖDcnY7:n`c&5])槏2h>A(VOnM[Bs.]=蝽_*zZ w*QcٷR $jʂjX_rYѠ< a1hz@ Fe/돹5vEy31r{R T/qhHFM(fY뾿Ιv%~8<.rpϞF0hjO;HaZ*= ݀Qd-^F"c_?h[?kFi( +vέP,%34rl.3UbJ6Sc<';s+T.S86=ϙdNgD^(VlXN^ D;W ) ~4(W\Bnsa܀xP;|I<>X`^]L#1N/[-=fphfGVyvIVAӈkRe~q06MR/ݞXנ:5mM-y- db}.#1țQ fhΔ=}:L|h&Ϳ|qaֻ^bQ!;Iv<ڏeDR&rhuF)LZJF|:6Qn0<427rdP6b'S,AMom.N.'9ub9cGyCvOd;Pq+^5u0cmiW:If .11VggTJHy4Qչ_\g9_`qXrONZWO+o>H&d 0hC7W?n])RS'I2CѡR;[0L$UtCǧA୕+s܌$,q]ǟE_j)9DʄQ=)kr,`cjY+j@j iX0ߵ +`oFaskiY oHĎYmn:0h7F]6b059q]6KZQ֓gRc ˵uRWmpKDL\S]jZI!;ٮ-QΑ}D{yxn>[LQzPk;jv ~QqY/SКիށ:B68`fByF*ZW(^Rģ V^J"k:I%mtv ^]2հjohG.`~;6W|k|B/mf̀M2_ T{-;jFD<NPs8)& kӉGnG,AP( ߕʂ}:Ld@yBrGPNm-yW/]Q:E+ c+M@r-3f:mu<4k&}i2 d[XT(sݖ#8V'NZ0#5px*C}=*|5 ^M+qjrP~YP{l\\A2?\;t@;DwGޭLN)|jrvI5z^MTk谱1X`4G\INh4_MdNRu`\iylSjzNm~abLT)чSlk<\ɲJa ж2ЃyF('0Q ЉHȁqʄK+JLf8P# !4&w% |s5e@-37E%RcRiv5dxsrN#">;>?Ib$9gL&nsԂ&n:* iVu &8ހ`o \2tB:u^\^.*`\UL}>44"Q6T8R?UB֠b.Q :M'::QF؄yc-\%wJ1†p\gl뉛'\G"fq?hG7\qJ"D\S.fܠic]6D;fuoVzf^#(*lMh<hxLVLlh'NgCa'u\6P]pTc  QuJC6.F.h<-2n"4$q3G4ntq;dJړ),Y?w*A^dOqK/m^r3+[̚CC3:.V07)w'9lp_Dz]PQ,[AN֠0mĈ/[-GKwy* Пg*\-` |7+?R}}]6eS@iКGEuM_98Lw֣N^e|J\ eAfkO`;2)he풑X>PT+AQv2h0o9;:53&ImhTU@%{&q,yu0˝le“Jt8ZbNvІlkbh RXldIX I~w&ɹ_^MZ@L  0VVE ]]oeMnSN-rᛖ F8 05SF<1 U%qxr؎lxPɓdY 4F| yd.m;T7)e`J"祉{l3D h-o=CB122_'s/:D1-ԷJ(lZLAmΐppH֑\F9SW 9d,;QUep!31u`K6|R\QݐRpꓟ4MБ9ofulXko_,D}zDZk4K׎2 PTeӦUV0-a)S2,r>p4@SG@ݚχ:SD',Qfկi[B lDHI]J)caT؍d{9Viq{X@1VVv^ f}qZ|s 8!i>  i(uj5;ǺaԣMaR ~P/c$ZJ> кI'ȏ|*uW%x_ 6J绯뛌ב\oEH[5IdO4g+ҥu{nʳ*\rCF#_KS4TBrƉ O.1C|A5?|b?wnHQeHۀ;QQoBL'X[~.8, ||J Lk FGI *Â͟>}5T*ZhdO@Ri`,t!ixmv[MaZ}'F+qpH\ (u6UɴFbIwl(?4f}h}6NxBDC ǖ%m684L@y%*Z:$0*R[^4%lӚT%Y5D2b~ n؁E: mxYiqoHud@HBnv^%PJFLL sCKhQƷ'(ѳ8%Mǁof\Jȸ9#9)J>$G4#*%zo3]ulV`.X҇&M6u3̰EApKdPk Π]ww6²LT׬Ve,2X[(^# fOy3upDZoXwLrJm?Aa>re<դ17n~Ot~"ϚrŠ$Jb߸%&~L>NH`]j0\Guh[KI$][b驠5v8N˴i8 vCDpс-BzݲD_fNJ]Pk T[R0hARi<,5ۋ]LCj?8ǟgxhM L Wv}e1}ڭ í>޺(%7mC ZTf;{%SiS <])6C0$81]t)\mxo[Z-xniV7%p[;s2 f(V+u' i8]$=tq^H&5M8[mѯp1|mRV[1T:Tvl |9W]TۮTщSROtH1:xh 9b\q8^NSuHr+4_qCNn2hEb fPL Fδ8HMpdڱkٛ up8Sr'LۙOp,7%{gH$vpH^Tnn y]e hM]?rL2Pz( ?M3dWk|BЙ$ K[Zk:Jp^rU3q m6[ل17ܞg=bGfWIB`YD:nm$emt̶}\pznسw/ ۥh2YM-k \S~$!2T㉛K d(eu#Ф=6 l4UwE44d_c.lj uPp&LS-g0&f2 T 5UFҺ_Bޓ_V." 0IiҹŸn5k-r$ߐ;֞dͰyo 5&vrtߘ<ó(80QeԞ)f8L)N/hiz2sPDC KTD:SeE6k? .tnD6i ]+Ȫo,3GΉ AqZ".dxHpMF2\0OCkAqI\""L(do?艚dVAEO$JښsUh"E^Ԕ^+4#T=ĝd>0W=]p&9o`F>ON "}c#g [̄!HB?^#@Gp5$n{WVuh/]\OBc6!8&HQX8wZ+o̎)Xm,!U$i4Czbdž GCQ)bTk6=\^ga6Yxy 4KX'DQYo6˔rVѸ[-Cc6jb}RskY'¬t]UD `1^w(*i']g،nVÈ@AbiA"_EPη"@V] `(  2O%Ri8| N/aZNmQu6T+nE^+WCNat@VJT:DE@aZK7jK\ ++iL!eE *aWc5"2@ zQ\-+J(w./XF.nYHQ HqLHP>&'>y\;y"H@ ʚ~ӗȈ`Q$%ϴ^+dyKe0R  ~nR[Fmw.{)*e)\HJ6I%/½ )Y쫫UI!icv"έ.!dXbTl6eYck jRvgvbNĖ: e+4\D?2P|@(Oz0Fq&4*HjFON3*ERKTYds~qp-Yx=Vq*dH[/6cXZvbe8ʭ¤Snl92iNjBӉ t,ebv)>d(, iDN9{CCACZ嫙$X^4}aX'mDݤ:v :Je@=GP EN'smewXZނ!*oHS?~uD5 :&kzyVA"MRg:(1M12pcSb ^>صaw,06A}M~ o*J\65 ,@}T˛坓VG9ԙO(21}$hÝ%pj ъPv E* e^*KXq (L,#i5 "ϵpWoD'6",1pOSUV Gbs?RglPbةvR)Zz͉vm>C<87!X빽vGtrͪhAtNS=vLZfTGZ'ZN}]l+QF41EČZLpL$*ו듣Hk\ 9o_nߺ 6+-&i[`MҦXQ.qlY1MpK;5*W\4ibl.eRi Mn5)OPRv6{))5-*ifxc3g"Rq9( =4Qڤc '7KbBߦYd 4;4ҴҦZ`UBwcbV]Sy-03go QP=(t9۟b0#]޳ąA毢̑L G`fvê~[ v/(eT40t-}m6j6`? -[ ^J }ZU 66E աfZIgE2Z$w󳧮3QPV|䮒SvK7lW@ *t-ƾtXm[E۞yϲ A$뿿\̛ Vi&bdd&rys4Fmo]1="GKY8ϓVb~3~?4bJǏSr'@ߟ~aE,7mn]: p뀯HHǷ#(bc-S0b93qL2YoOj:ERa~"r .cXȨYLaS̢U=RugFfKQw&Ol>G+@,N gUE&64/y``&58XНqϓl@_Bˆ%Z7;<\Υ2DM7<|3wȔ ׼kzsyK;ZW}y.|1A M/h]3HB>H:B sx) Nd Ӵ%e~&`֍X4"RHQk*@kcxY9"!. W_>}O;VW s hfM `lzeȻojT<;1^fCaj?lY7ƢeeoF ` }e?dF[˖ ŽQfP~Bc@ϧ k1y\˟}cX>Jf9ZNWże+;;*wse/i=X^7G+ӺWY`ic#>Y]h&C&Ne\-keu7ymstd#64ȌSľд:g6"uP8ֵY C3[6Eb˾mer}8ʸcE 49خ$Y HYe;G)NR$RjzZo% avwY)4 a`^9Q#0Q˒М(geyr}$. I *Hy nՑۍ+_bNwŝS c!T1Grh7/4ORhwoHc i ($ 9yG0Hhs1.R>96_öE\"jZ]n&$a ֖HKecy^`JV#ړK Ѡ i콺MBW A WRR*zT׊cN,lOrU-1펬E ~̋n9EUHPVBya]GXW@9 PqRA$;4 ?cҵF_j:/oڮW0bID: :aOj^;0+ Bȳu ΃erņ3½::G}[)ꚦ2=#@:[vB{h9y=fGw9N! ^prED,%<\<;[쎋`]ɋ_b Oaay}IU| TEHJw.]Ao[V-FO);ԆM_/JTҺR>~?{°rЉ e\|"u\Em\O’iy2 U_oQB~ j+ L*֧&XT?c D8;´W’N"^ {@R𼧁*Ok6|U.jૈc z $VײC(W F8EURT]T[omKY=V~4R`.r?R6Hm{=6RѼF3~&IhoLjɧas,OgX+Jt&Al"ck2UbHRi֗X:D0@0/HE{>Ű*e8aJarB]*-m%RimKb:goyMR:e]1Qt_g{] se$­ɯ<&[d[w330AJQ?ܟ peJ4ޤ D_:&+F]5kSYz`5B{ܩ)+`=rm]NΨr Aj:lSR^\E=Q_|҂5~a#mV&rcZa?Kxmn749%Wӕ C@<~#WԊo5b](J4:@\RWlUNKRrdP(,f 2Ԣ#']/Vu:[l]9\_~Bz"s`ѿDh qZoȂħ^Nѯ~\zٽ- 8?=c|__I$CgR~?&jƍ_pc\ l<ԉ8I{VRQ5ǩϚz\ݏ!F2+3)wŬ,(ikvVDZvY 6> 6 Y9=>%&+epѺ;{@hM tQÑʱ͘Dvq{Hc4KgtQbN,I, DЉP|V_{_gxD#Qhcyێdݧ> kZ. {F!lk]=<[U/S؍IXMpE2ՆC"$A^ xE?zVt0zxo|ddm.񷇰J-#`9:TVb@9#X~c^K'qrKx*0)OQJ@\] sg 1(l q[&ECK (] #e\Sh*m7)7&ZB:d8h߾FxRϐZa4R@Jv֛bm&%\@h!›<>k25 3BlAլ~hhNR),|: j4|YkžXOnKr`~:2Pea5iRj8j64ՂCj/ !9.B?IlXvED%qbD<5ŪCig[GP&>(dh{2%B%. ^\#C.?PM>N?~|ܣZ*]y].c#`x&(iUO^x$qp 0ߟwUT\Uq;Q-O%6sI3GV"fJl6+G(UX]h_Orxlm׶qk1Mb]؞֛ҕ<(|mڕ@M9̌/]~^Byq( ĉwL\AeԾ/b$1i!jCèQ́DtVŋuuOq] GDV& zV~hJH!:{DLV ?[o!p RAjaI6Z4?j*sM]M~h}L]唽I|aZon;cv6jqA$Yh FKN}#{͛㪩>E.p*5#_EԂhz%$"6@."N'CR!4ӿ79>:[艬гmKT[, (,u՛~0!Ԇil=*gqd7 ivrJ2.r CAhRZT[ m9'=F\7.&Is֋2x$@2MyhFɏ эq+kweF%6@]bIKk5ɣwָ5Fg5+҅{B1VB)5DlzBҽjPcB:G4ms Dw8^N!n mzP]na >4htmѨYᯆaVE~Jv9¤ ׵_]T IBP5stE"rYa[:T KW]5-|!S3-eDGK"h`3!% @Mn䇧8 V)Q#'A |&]d{x!HZ]7<5Ssi%V-L/=qG>̳l|1RyisgaX8MʿԜ˒_+o5=KTgU  Jt>a-bאlMJvc^q9NOWoM}{ujɳa>U^ׁyڽgOA$a-dDE_-AL$)h{4Y·xcEVa+;:NFiF*ykS$1/ 2)BO4奾#2O^EL!_zFgHuvNV*QGll9ش}5stq_]zɠn+slm]Iǧɥ| u_SR|C(s1-=Hҽ0ێx(0tO&v PiA}H HKw&ƫdu۽+|6c DcUxIDK(L`d0XT3iBR=?7u%F]2.f[)gc} AK/oL uz},z<^_ݶs"*0Ǖ]9VqmcP#G4 Pz;Oe^reQ})ƋPrZ%_!C8;Tn؁Tk` 퐩Ltכpf2_3,W+]Zq'S+=l(ֶH$-T2 GX~ek*Zh}Mu$#t . %>kQf)xdaVw,EC;@k R&3 jy{&p<njۗ<-Ґ8el2QAFN# &4pJmnQ^1T-|E!t8;R20Ur>l1~Țd[X>/2#YfIM8սӂ}Fyo`#d:i&p}vwUsDYxgiVfD~;iSyEԟ.J"hM #\ T5 476N\ s3Y|.3kt?qA ):7h[)NQ]' V5Ov1 :..`DXתqŸ`I[x$I "x\{dlQKoZXG \8+]Wg3j }M&B'Q[t(,Ru ^ZH+/1:#ýV)C!/,6uՐIl,j4]q5?}#/o~?O˳bw2.l{@YdIXxl QmSNm3!(i0DQ =] =ʒe`@Nz,JUhQ=8h& ^IAhr!Q 9`ӑ4_h*_33phx#Y]Q6>ΠBu)f-Uש.[Ob!ℋ?A W{1 ]*ac4ޟiRdnڠKt>3]\e!V7"5QR= ͺc#ⱷSQJrwiڤܝ*t h*{{ΙDbH{tyC&VeUp;&? ҳy:bS-NŨ04a,U!\/)lw_ %R0R2u_ ;'b o0ltOyer#d9:i8q@|9UkQ&i/Xf,IB~jou#)*ȑtTSE*;a7˲LVV-E$ԞoO)-*aޖW iqu}WnJqs=@$#&-qRv_ET s5F),@ʦR-gW~L eC,=)\/̫s):U[(#wMħ-(EMaI-)bZ{-rVP]vyS\̰Xj*~Vf!Yzb5V/tUtRC&'қExl+hUdBH蘹+j&e!0h!V*mv!:I̶O]0d@&VQ3)i{l$= 01dG£`- 0nQsu,XQ$ZXR3yam|i-kDX5 'Eu z6y *p0N'zw vGTj[u[ϚWRxe{z`*0q`^2hwPg^iyKfڀ#BZ@a@k'w<=Sz%uPժu__M,|k"$w݇8+PG@r#A?q1TaM}8eZxOqQdhʷ}`Of'Bm36MB>:MZHP҂#N T$lܫӈo3ϯd E^Of8`Lg0\9,%yo]F__Ly5Nq2?4<a/_[ݽkCPfk.OӇ/4*1mh[͛oQn~4ެ6ZbS-[,WKf;V \aHBI% helMY3aWʡ,6jߵxLWim*= -gqr82YE ``#}t4;z*,IY#1 Zμ2<Q->$3P贛bx1χqξɮvb @x>WiVĘ3_,8vxg0EwK3 i9? }B|}[z`jȚ`Xi\}Rǫϗ00NZͷoz´LEu4HzX` %`G.tONf ':]YZ Ȳ~I oYCSZ7#ao)nBAE71P~/&4tج'Ii,+C V@O s7 _rp>"M)z|!GR P\OM[ίlvIS]Y $YS9?zM4HQAvRq/ϊqfN3>(vBrno.GKшn|,vvgAy!0bfxR=Vm}t-KoNmZ4N7y9tZ4^6CY gbvi\zFҀb? !^βCL'_ofEgҼA=-2LXɱ؃8eK \ح!qJ}t0C|L#*(3m4&ٹz`J r<pF9wTwɦFrY-,g ϧ$wt;0 ; cѻ~fP#qiH?_!k#ez-wq !Z&[g4XM5Im W϶ܞ=;T٢6`ř]c`!>o6uͱ.n'RXnۡDMko;OQ=$oRԠ Remote Patient Monitoring With ProRITHM

Empowering Healthcare with Advanced
Remote Patient Monitoring

Leverage Technology to Reduce The Patient - Doctor Geographic Distance
With a Proactive and Predictive Screening System.

Simplifying Remote Patient Monitoring And Early Detection with proRITHM

At proRITHM, we are transforming patient care with our groundbreaking technology. Our advanced RPM (Remote Patient Monitoring) platform, equipped with cutting-edge proRITHM devices, continuously tracks essential health metrics in real-time. This ensures improved health outcomes and provides peace of mind for both patients and healthcare providers.

Introducing the Award-Winning proRITHM Wearable Device and IR Platform for Continuous Remote Patient Monitoring

Enhancing personalized patient care, optimizing clinical workflows, and empowering proactive clinical interventions

 

Stick it on for convenient
remote data collecting

Cost effective continuous
health monitoring

Continuous vital sign monitoring,
personalised notification and  more

Bluetooth wireless
data transmisssion

Comfortable design with
changeable 24hrs adhesive

Wearable
device

Explore Remote Monitoring Solutions!

The proRithm IR platform features RPM proRITHM devices designed to monitor Heart Rate, Cuffless Blood Pressure, Skin Temperature, Respiratory Rate, Oxygen Saturation, and Heart Rate Variability. With ongoing additions of new devices and integrations, its capabilities continue to expand, enhancing patient care even further.

Continuous proRITHM monitoring throughout care settings

Enhancing Patient Care

proRITHM empowers healthcare providers with the tools they need to deliver superior care. By leveraging real-time data and advanced analytics, our platform helps in:

Convenience And Confort

Monitor your health from the comfort of your home, reducing the need for frequent visits to the doctor.

Tailored Alerts for Vital Sign Monitoring at Every Level

proRITHM alerts healthcare providers when vital sign deviate from predetermined parameters, enabling timely action and mitigating the rost of complications.

Improve Outcomes

Make informed decisions that lead to better health outcomes.

Early Detection

Identify potential health issues before they become serious.

Patient Engagement

Enhanced patient engagement and adherence to treatment plans.

Benefits for Hospitals, Home Care and Ambulance

A Detailed and High-Resolution Overview of an Individual’s Health Status

Present Parameters

Upcoming Parameters

Accuracy

Our devices provide precise and reliable data.

Ease of Use

User-friendly design ensures hassle-free monitoring.

Integration

Seamlessly integrates with existing healthcare systems.

Support

Dedicated customer support to assist with any needs or questions.

Discover More With proRITHM

Ready to learn more? Contact us today to see how proRITHM can enhance your healthcare experience. We invite you to explore the full potential of proRITHM. Learn more about our advanced features, latest device updates, and how our platform can enhance your healthcare experience.

GLOBAL STANDARDS AND PRACTICES

Client’s Testimonials

Building a Stronger Future in Partnership

FAQ’s About proRITHM

How does proRITHM IR platform and Device Works?

The proRITHM IR platform operates by integrating a range of devices and technologies to collect and analyze patient data in real-time. This data includes vital signs such as heart rate, blood pressure, temperature, respiratory rate, oxygen saturation, and heart rate variability. The platform utilizes advanced algorithms and artificial intelligence to interpret this data, identifying patterns, trends, and abnormalities that may indicate changes in a patient’s health status. The proRITHM IR device is a key component of this platform, specifically designed for remote patient monitoring. It is equipped with sensors to measure various physiological parameters and securely transmits this data to the proRITHM IR platform for analysis.

What Are The Parameters Monitored By proRITHM?

proRITHM monitors various physiological parameters, including but not limited to:

1. Heart Rate
2. Cuffless Blood Pressure
3. Skin Temperature
4. Respiratory Rate
5. Oxygen Saturation
6. Heart Rate Variability

These parameters provide valuable insights into a patient’s health status and help healthcare providers monitor their well-being remotely.

What are the Use Cases of proRITHM?

Use case 1: Automated Patient Monitoring for Non-ICU Beds in Hospitals, Including:

– High Dependency Units (HDUs)
– VIP Rooms
– General Wards

Use case 2: Upgrade any ambulance to a Smart Ambulance equipped with the proRITHM Device.

Can I trust proRITHM to keep my data secure?

Absolutely, proRithm holds ISO 27001:2013 certification, ensuring compliance with international standards for information security. Access to stored user data is restricted to authorized individuals only.

It is HIPPA Compliance.

How Accurate is this?

Studies have demonstrated that proRITHM achieves an accuracy rate of 96%, comparable to that of medical-grade devices.

How is proRITHM different from an ICU Monitor?

proRithm serves as a complementary solution to ICU monitors, specifically tailored for non-ICU settings such as:

– High Dependency Units (HDUs)
– Step-down ICUs
– VIP Rooms
– Infection Wards

It is designed to provide continuous monitoring and early detection of health changes in these environments, enhancing patient care beyond traditional ICU settings.

What are the Patient Safety Standards By proRITHM?

proRITHM adheres to a range of international standards and certifications to ensure the quality, safety, and effectiveness of its medical devices and services, including:

1. ISO 13485:2016 – Quality Management System for Medical Device Manufacturing: proRITHM follows the requirements of ISO 13485:2016 to maintain a robust quality management system throughout its manufacturing processes, ensuring the consistent production of safe and effective medical devices.

2. ISO 27001:2013 – International Information Security Standard: proRITHM complies with ISO 27001:2013 standards to establish and maintain an information security management system, safeguarding sensitive patient data and ensuring confidentiality, integrity, and availability.

3. IEC 60601-1 – Technical Standards for the Safety and Effectiveness of Medical Electrical Equipment: proRITHM adheres to the technical standards outlined in IEC 60601-1 to ensure the safety and effectiveness of its medical electrical equipment, providing assurance to healthcare professionals and patients alike.

4. CDSCO Certified: proRITHM’s medical devices are certified by the Central Drugs Standard Control Organisation (CDSCO), indicating compliance with regulatory requirements in India for the manufacture and sale of medical devices.

5. RoHS Compliant: proRITHMS’s products adhere to the Restriction of Hazardous Substances (RoHS) directive, restricting the use of certain hazardous materials in electrical and electronic equipment, promoting environmental sustainability and consumer safety.

By adhering to these standards and certifications, proRITHM demonstrates its commitment to quality, safety, and compliance, ensuring the delivery of reliable and effective healthcare solutions to healthcare providers and patients worldwide.

Is proRITHM MRI Safe?

proRITHM is not compatible with MRI machines.

With Our Strategic Partners,
We Propel the Healthcare Revolution Forward

Schedule A Demo

Join the future of healthcare with proRITHM. Experience the peace of mind that comes with knowing your health is being monitored by the best in the industry.

error: Content is protected !!